Valuation DexCom, Inc. Boerse Muenchen

Stocks

Market Closed - Boerse Muenchen 16:43:10 2026-09-15 EDT			5-day change	1st Jan Change
75.00 ^EUR	+2.46%		-2.14%	+28.02%

09-14	DexCom Promotes CFO Jereme Sylvain to Additional COO Role	MT
09-14	Dexcom, Inc. Announces Appointment of Jereme Sylvain as Executive Vice President and Chief Operating Officer, Effective September 14, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	52,042	43,740	47,945	30,377	25,885	32,623	-	-
Change	-	-15.95%	9.61%	-36.64%	-14.79%	26.03%	-	-
Enterprise Value (EV) ¹	52,692	45,068	49,813	31,073	26,209	31,862	31,561	30,746
Change	-	-14.47%	10.53%	-37.62%	-15.65%	21.57%	-0.94%	-2.58%
P/E	346x	138x	95.5x	54.8x	31.8x	34.7x	29.1x	24x
PBR	23.1x	20.5x	23.1x	15.1x	9.3x	11.5x	9.57x	7.36x
PEG	-	1x	1.6x	5.94x	0.7x	1.8x	1.5x	1.1x
Capitalization / Revenue	21.3x	15x	13.2x	7.53x	5.55x	6.24x	5.62x	5.05x
EV / Revenue	21.5x	15.5x	13.8x	7.7x	5.62x	6.09x	5.44x	4.76x
EV / EBITDA	111x	60x	49.1x	28.1x	19.4x	19.1x	16.4x	13.9x
EV / EBIT	142x	92.9x	69.3x	41x	27x	25.5x	21.8x	17.9x
EV / FCF	989x	148x	97.3x	49.3x	24.3x	31.2x	25.9x	20.9x
FCF Yield	0.1%	0.68%	1.03%	2.03%	4.11%	3.21%	3.87%	4.78%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.3875	0.82	1.3	1.42	2.09	2.495	2.969	3.596
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,448	2,910	3,622	4,033	4,662	5,230	5,800	6,461
EBITDA ¹	472.7	751.6	1,014	1,105	1,349	1,666	1,921	2,218
EBIT ¹	370.7	485.1	718.6	757.1	969.3	1,247	1,447	1,722
Net income ¹	154.7	341.2	541.5	576.2	836.3	974.4	1,149	1,409
Net Debt ¹	650.1	1,328	1,868	695.9	323.2	-761.1	-1,061	-1,877
Reference price ²	134.24	113.24	124.09	77.77	66.37	86.45	86.45	86.45
Nbr of stocks (in thousands)	387,688	386,258	386,374	390,595	390,016	377,361	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	29.21x	4.03x	15.58x	2.49%	178B
MEDTRONIC PLC	19.84x	3.61x	12.91x	3%	120B
CENCORA, INC.	17.86x	0.21x	13.03x	0.73%	62.25B
BECTON, DICKINSON AND COMPANY	35.25x	3.41x	11.68x	2.15%	49.82B
HOYA CORPORATION	27.51x	6.75x	17.39x	1.45%	48.54B
DEXCOM, INC.	33.94x	5.96x	18.72x	-.--%	31.95B
MEDLINE INC.	42.07x	1.24x	11.48x	0.22%	28.59B
WEST PHARMACEUTICAL SERVICES, INC.	41.42x	7.26x	26.04x	0.25%	25B
TERUMO CORPORATION	16.86x	2.69x	9.53x	1.64%	21.59B
Average	29.33x	3.91x	15.15x	1.33%	62.9B
Weighted average by Cap.	27.35x	3.76x	14.74x	1.9%